← Leaderboards
Philip Measor
Liquilume Diagnostics, Inc.
$90,702
Attributed
$272,105
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$272,105 · 1
By mechanism
R43$272,105 · 1
Top collaborators
- Aaron R. Hawkins1 shared
- Holger Schmidt1 shared
Most similar at Liquilume Diagnostics, Inc.
Same institution · by research overlap
- Aaron R. Hawkins$1,176,029
Others in their field
Top investigators on “Antineoplastic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,409,738
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Gregory H Reaman · National Childhood Cancer Foundation$94,722,934
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Walter John Curran · Thomas Jefferson University$55,187,978
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
Research focus
Antineoplastic AgentsAreaBaseBiomarkerCancer DetectionCancer DiagnosticsCancer ImmunotherapyCancer PatientCellsCommunicable DiseasesCompanionsCostDetectionDiagnosticEvaluationFda ApprovedGenetic AnalysisGenetic ScreeningGenetic TranscriptionGenomeGenomicsGoldGovernmentAlgorithms